Importantly, ectopic overexpression and constitutive hyperactivation of STAT3 suffices to suppress the growth-inhibitory and apoptotic effects of nintedanib on cancer cells, revealing that the activation status of STAT3 [32,33,34,35,36] might be crucial in determining its non-angiogenic cancer cell-targeted activity. Here, STAT3 is linked to cancer.